New York (December 18th, 2012) - Oncolytics Biotech Inc. (NASDAQ: ONCY) shows bullish trend as the stock made a sharp up movement in its previous trading session. It opened the session at $3.14 and remained in $3.13 and $3.69 price range. The stock closed 9.03 percent higher at $3.38. Oncolytics Biotech’s first support level is at $3.34. Upon breaching this level, the stock may go as low as $3.26. On the upside, its first resistance level is at $3.80. The company recently reported positive results for the Phase III of its new drug for neck and head cancers, Reolysin.
Find out what traders and investors need to do when it comes to ONCY by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=ONCY
Greenway Medical Technologies Inc. (NYSE: GWAY) stock closed its latest trading session at $16.04, down 1.29 percent from its previous close of $16.25. Its latest trading volume has been recorded at 235k shares, in contrast to the average daily trading volume of 197k shares. The stock opened the session at $16.24 and touched its highest price point at $16.26.
Greenway Medical Technologies stock’s lowest price point for the session stood at $15.60. The stock’s MACD chart shows neutral trend and the stock may test its first support level at $15.23. Greenway Medical Technologies provides information technology solutions for healthcare services. The company is based out of Georgia.
Find out if GWAY could bounce back in the very short term by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=GWAY
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
WALL STREET REPORT[email protected]